Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...

Genes shape brain structure and may influence neurological disorders like Parkinson’s and ADHD, revealing new insights into brain health.

The npj Parkinson's Disease report uses an approach called "systems biology," which uses AI to integrate and analyze multiple different forms of information from genetic, proteomic, pharmaceutical ...

“The RMAT designation for AB-1005 underscores the high unmet medical need and the potential of this investigational gene therapy to make a difference for patients with Parkinson’s disease ...

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

investigational gene therapy for the treatment of moderate-stage Parkinson’s disease AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer ...

Germany-based Bayer’s wholly-owned gene therapy company AskBio today announced that its investigational gene therapy AB-1005 ...

Ibogaine by David Dardashti, a leading voice in the exploration of ibogaine's therapeutic potential, is closely analyzing a new study published in EMBO Reports that sheds light on the intricate ...

John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...

A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...